Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Hims & Hers Health recurring revenue grew 111% YoY, boosted by personalization and chronic care. Forecasting $2.35B revenue ...

Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...

Coca‑Cola has announced that it will launch a new version of its iconic Coke in the U.S. this autumn, sweetened with ...

XOOX is turning backpacks into portable entertainment hubs, while CyFireAI helps small businesses stay ahead of cyber threats ...

The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & ...

Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Abbott (ABT).

NIKE Inc.’s NKE ongoing efforts to streamline inventory and reset the marketplace remain central to its turnaround strategy.

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...